0

Dragana Sarenac

Institute for Cardiovascular Diseases Dedinje; University Hospital, Serbia

Title: ACC reflecting atributable circulatory concept - Revascularization all around the globe

Abstract

Myocardial revascularization -What is new in ESC and ACC revascularization guidelines. Why we need to embrace it in everyday practice. When we can use different antiplatelet therapeutic options in those patients. How can we implement mode of artificial intelligence after primary PCI. When and What is the right definition of ACS – ESC 2023. New guidelines and urge for complete revascularization.

ACC 2021. Main pathways

Why and how to assess High Bleeding Risk (HBR), seen in about 20% of ACS patients. Can we measure periprocedural risk and what types of de-escalation antiplatelet therapy can be used.

CCS – Chronic Coronary Syndrome (stable angina)

ESC 2019. guidelines. ACC 2023

What are patient risk profiles number 1, 2 and 3. Why we should use Guideline Directed Medical Therapy, the proven benefit in CCS. Different types of revascularization therapies, OMT (Optimal Medical Therapy) vs PCI vs CABG (Coronary Artery By Pass). What is OPTIMUM Registry and who are the patient’s ineligible for surgical revascularization.

The role and definition of Prehabilitation. All those aspects through interactive presentation, discussion and examples are going to be presented.

Biography

Dragana Sarenac was born in 1969 in Belgrade. She is a doctor of medicine at faculty of medicine Belgrade University in 1993. She is a specialist of internal medicine (2000), subspecialist in cardiology (2017) master of medical sciences (2001), ongoing PhD. She has employed as a cardiologist at Institute for Cardiovascular Diseases Dedinje from 2000. She trained also in Hammersmith Hospital, London Ulleval University, Oslo. She has a few publications and a lot of abstracts and sessions at national and international cardiology meetings. She is a member of the Association of Cardiologists Serbia, ESC, HFA, EAPCI, EAPC, ESC WG on thrombosis. Her narrow interests in myocardial revascularization, antithrombotic therapy, cardiovascular therapy in elderly. She speaks English, partly French, Italian.